A meta-analysis for Lianhua Qingwen on the treatment of Coronavirus disease 2019 (COVID-19)
Background: Traditional Chinese medicine (TCM) has been proven to played a great important role on the treatment of COVID-19. As one of the drugs recommended in Chinese guidelines, Lianhua Qingwen Granules or Capsules (LQ) are widely used.This systematic review and meta-analysis amis to evaluate the...
Saved in:
Main Authors: | Jieqin Zhuang (Author), Xingzhen Dai (Author), Qihua Wu (Author), Hairong Cai (Author), Xue Fu (Author), Weizhang Zhang (Author), Bojun Chen (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and Safety of Chinese Medicine Lianhua Qingwen for Treating COVID-19: An Updated meta-Analysis
by: Yapeng Li, et al.
Published: (2022) -
The Adverse Reactions of Lianhua Qingwen Capsule/Granule Compared With Conventional Drug in Clinical Application: A Meta-Analysis
by: Caiyun Hu, et al.
Published: (2022) -
Establishment of an anti-inflammation-based bioassay for the quality control of the 13-component TCM formula (Lianhua Qingwen)
by: Shuaishuai Chen, et al.
Published: (2021) -
Screening for Anti-Inflammation Quality Markers of Lianhua Qingwen Capsule Based on Network Pharmacology, UPLC, and Biological Activity
by: Yongfeng Zhou, et al.
Published: (2021) -
Qualitative analysis of chemical components in Lianhua Qingwen capsule by HPLC-Q Exactive-Orbitrap-MS coupled with GC-MS
by: Shuai Fu, et al.
Published: (2021)